Market Report, "Ovarian Disease - Pipeline Review, H2 2012", Published
Global Markets Direct's, 'Ovarian Disease - Pipeline Review, H2 2012', provides an overview of the Ovarian Disease therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Disease. 'Ovarian Disease - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release